Entrada Therapeutics Inc Financial Overview
Entrada Therapeutics Inc's market cap is currently $428.82M. The company's EPS TTM is $-1.06; its P/E ratio is ―; Entrada Therapeutics Inc is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
